CMPSNASDAQCompass Pathways Plc

CMPS price activity

Last Price

Change (24hr)

USD (%)

Volume

Volume (4w avg)

Previous Close

N/A

Last Trade

CMPS price performance

5.03%

30.68%

113.26%

YTD

209.14%

CMPS price fundamentals

N/A

Shares Issued

N/A

Earnings Per Share (EPS)

N/A

Dividends Per Share (DPS)

N/A

P/E Ratio

Price market cap

Market cap

N/A

US-NASDAQ rank

N/A

Sector Rank

N/A

CMPS details

View company profile

View company website

View US-NASDAQ Official Page

CMPS dividends

CMPS Market Signals

More ways to discover

Browse United States news Discover NASDAQ signals Browse all NASDAQ stocks Browse all NASDAQ ETFs

Compass Pathways Plc (US-NASDAQ: CMPS)

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

Price: $14.72

Sector: Healthcare — Medical Care Facilities